ORCID as entered in ROS
https://orcid.org/0000-0002-0009-3337
Select Publications
Conference Papers
, 2021, 'Single cell RNA sequencing of gluten-specific CD4+T cells reveals a novel gene expression pattern with NK-like cytotoxicity', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY, pp. 96 - 96, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000753366400285&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'O12.2 A novel analysis of NSW HIV surveillance data to highlight HIV prevention program impact and gaps', in HIV, BMJ Publishing Group Ltd, presented at
, 2020, 'RNA-DIRECTED EPIGENETIC SILENCING PROTECTS HUMANISED MICE DURING HIV CHALLENGE', in SEXUAL HEALTH, CSIRO PUBLISHING, pp. XXVII - XXVII, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000598625300036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, '"HIV-1 controllers" - what's their secret?', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 74 - 74, presented at
, 2016, 'Fc gamma R ectodomain probes measure anti-viral IgG effector function', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 1256 - 1257, presented at
, 2016, 'HIV induces interferon stimulated genes in two phases in macrophages while inhibiting interferon induction', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 630 - 630, presented at
, 2016, 'Neutrophils mediate potent and rapid anti-HIV antibody-dependent functions', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 73 - 74, presented at
, 2016, 'Neutrophils mediate potent and rapid anti-HIV antibody-dependent functions', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000395394300142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Transmission modes of HIV and risk of infection of antiretroviral resistance among treatment-naive HIV-infected people: a global systematic review and meta-analysis', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, GERMANY, Berlin, pp. A65 - A65, presented at
, 2013, 'Sequencing antiretroviral therapy to maximize patient safety: could we move away from ritonavir, abacavir, tenofovir and efavirenz (RATE) - agents that concern prescribers and patients? A feasibility study and call for a trial', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, BELGIUM, Brussels, pp. A51 - A51, presented at
, 2013, 'Decreased HIV-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Infected Subjects on cART: Implications for Therapeutic Vaccines', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, INC, SPAIN, Barcelona, pp. A52 - A53, presented at
, 2013, 'Impaired Early HIV-1 Nef Function in Spontaneous Viremic Controllers', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, INC, SPAIN, Barcelona, pp. A83 - A84, presented at
, 2013, 'QUANTIFICATION OF HUMAN CYTOMEGALOVIRUS-SPECIFIC T-CELL RESPONSES IN PAEDIATRIC PATIENTS FOLLOWING HAEMATOPOIETIC STEM CELL TRANSPLANTATION', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 13 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323685200040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'Proviral DNA testing of HIV tropism in the Maraviroc Switch Collaborative Study (MARCH) - results of a three-phase quality assurance (QA) programme', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CANADA, Toronto, pp. A144 - A144, presented at
, 2011, 'SEQUENCE SPECIFIC INDUCTION OF HIV-1 TRANSCRIPTIONAL GENE SILENCING TARGETING NF-kappa B SEQUENCES BY SIRNA WITHOUT ANY OFF-TARGET EFFECTS OF OTHER NF-kappa B DRIVEN GENES', in JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, pp. 425 - 425, presented at
, 2011, 'Performance of quantiferon-cmv (r) and whole-blood cd4(+)cd25(+)cd134(+) assays in identification of human cytomegalovirus-specific t-cells in children post-haematopoietic stem cell transplantation', in Internal Medicine Journal, Blackwell Publishing Asia, http://dx.doi.org/10.1111/%28ISSN%291445-5994
, 2011, 'Primary Immune Responses to Vaccinia Virus Vaccination: The Role of Cytotoxic Effector CD4+ T Cells in the Generation of Human T Cell Memory', in AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, pp. A129 - A139
, 2010, 'Most HIV DNA in PBMC is present in non-gut-homing, resting central memory CD4 T-cells', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Dubrovnik, CROATIA, pp. A44 - A44, presented at
, 2009, 'Evaluation of adipose gene expression and mitochondrial DNA in healthy adults over a 6 week course of NRTI and/or PI treatment. Indications of divergent effects', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A10 - A11, presented at
, 2008, 'HLA Footprints in HIV-1 Drive Phylogenetic Clustering and Inter-Clade Variation', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT INC, SOUTH AFRICA, Cape Town, pp. 75 - 75, presented at
, 2008, 'Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial', in The Lancet, pp. 1881 - 1893, http://dx.doi.org/10.1016/S0140-6736(08)61591-3
, 2008, 'Early CD8+T Cell Responses are the Major Contributors to the Later Viral Set Point', in AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, Larchmont, NY, USA, pp. 7 - 7, presented at
, 2008, 'Long-term Stability of Compensated CTL Escape Mutations following Acute HIV Infection', in AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, Larchmont, NY, USA, pp. 78 - 78, presented at
, 2008, 'Reversion of HLA-Associated Polymorphisms in Gag, Pol and Nef during the First Year of HIV Infection: Sites, Rates and pVL Correlations', in AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, Larchmont, NY, USA, pp. 76 - 77, presented at
, 2006, 'Transient CCR5+ CD38+++ CD4+ effector TH1 cells are an early component of the primary immune response to vaccinia and immediately precede IL-2+ memory CD4+ T cells', in CYTOMETRY PART A, Wiley-Liss, pp. 400 - 400
, 2005, 'Optimizing 9-colour analysis of gut-homing CD4+T cell subsets', in CYTOMETRY PART A, WILEY-LISS, AUSTRIA, Queensland, pp. 400 - 400, presented at
, 2005, 'Development and optimisation of a culture amplified multiparametric intraceilular cytokine assay for the assessment of vaccine immunogenicity', in Tissue Antigens, Blackwell Munksgaard, pp. 499 - 499
, 2005, 'TCR clonotypic analysis of CMV antigen-specific CD8+ T-cells from formaldehyde fixed peripheral blood', in Tissue Antigens, Blackwell Munksgaard, pp. 573 - 574
, 2003, 'HIV Lipodystrophy Case Definition Study Group. Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. 57 - 57
, 2003, 'Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. L73 - L73
, 2002, 'Disrupted expression of lipid transport genes in monocytes of individuals with HIV-associated lipodystrophy - an additional risk for cardiovascular disease?', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L8 - L9, presented at
, 1998, 'Restoration of immunity with antiretroviral therapy', in AIDS, LIPPINCOTT WILLIAMS & WILKINS, pp. S3 - S3, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000077311300010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1997, 'Therapeutic vaccination with p24-VLP and AZT augments HIV specific CTL activity in asymptomatic HIV-infected individuals.', in Australasian Society for HIV Medicine 9th Annual Conference, Adelaide, Sth Aust, presented at
, 1997, 'CD8 activation does not totally normalise in treated primary HIV infection despite undetectable viral load; evidence for ongoing viral replication?', in 6th European Conference on Clinical Aspects and Treatment of HIV-Infection, Hamburg, Germany, presented at
, 1997, 'Reversal of CD8 activation in patients with primary HIV infection treated with AZT, 3TC and indinavir.', in 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, presented at
, 1997, 'Reversal of lymphocyte RA/RO ratios in patients with primary HIV infection treated with zidovudine, lamivudine and indinavir.', in International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, St Petersburg, Florida, USA, presented at
, 1997, 'Effect of therapeutic vaccine p24-VLP and AZT on immunological and virological markets in asymptomatic subjects', in 4th Conference on Retrovirology and Opportunistic Infections, Washington DC, USA, presented at
, 1996, 'Can antiviral therapy restore immune function?', in AIDS, RAPID SCIENCE PUBLISHERS, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VU96300005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1996, 'Effects of therapeutic vaccination (p24-VLP) and AZT on immunological and virological markers in asymptomatic subjects', in 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England, pp. 137 - 137, presented at
, 1990, 'LIMITED ROLE OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN UNSELECTED PATIENTS WITH CEREBRAL ISCHEMIC EVENTS', in CIRCULATION, AMER HEART ASSOC, pp. 110 - 110, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1990EC76400454&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Filter by type
https://orcid.org/0000-0002-0009-3337